Related Experiment Video
Updated: Feb 25, 2026
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
7.3K
Discovering intratumor heterogeneity: the next frontier for pathologists
1Department of Pathology, Cruces University Hospital, Biomarkers in Cancer Unit, Biocruces Research Institute, University of the Basque Country (UPV/EHU), Barakaldo, Spain.
Pathologica
|July 28, 2017
Summary
Detecting intratumor heterogeneity, a key challenge in cancer medicine, requires advanced methods. Current tumor sampling techniques are insufficient, necessitating updated pathologist protocols for accurate detection.
Area of Science:
- Oncology
- Pathology
- Genomics
Background:
- Intratumor heterogeneity (ITH) is a significant challenge in modern cancer medicine.
- High-throughput DNA sequencing reveals widespread ITH in malignant tumors.
- ITH exhibits complex temporal and spatial dynamics, making each tumor unique.
Purpose of the Study:
- To highlight the critical role of pathologists in detecting ITH.
- To address the inadequacy of current tumor sampling protocols for ITH detection.
- To advocate for the adaptation of sampling methods to meet modern oncologic demands.
Main Methods:
- Review of current understanding of ITH based on advanced sequencing technologies.
- Analysis of the limitations of existing pathological sampling techniques.
- Discussion of the evolving role of pathologists in cancer diagnosis and treatment.
Main Results:
- Malignant tumors frequently display high levels of intratumor heterogeneity.
- Existing sampling protocols are insufficient for reliable ITH detection.
- Pathologists are central to ITH detection but require updated methodologies.
Conclusions:
- Accurate detection of ITH is essential for effective cancer treatment.
- Pathologists must adapt traditional sampling methods to incorporate advanced techniques.
- Evolving pathological practices are crucial for a multidisciplinary approach to cancer care.
